Your browser is no longer supported. Please, upgrade your browser.
Settings
CVET Covetrus, Inc. daily Stock Chart
CVET [NASD]
Covetrus, Inc.
Index- P/E33.52 EPS (ttm)0.84 Insider Own3.20% Shs Outstand109.76M Perf Week2.44%
Market Cap3.09B Forward P/E29.82 EPS next Y0.94 Insider Trans- Shs Float98.58M Perf Month-13.87%
Income- PEG1.90 EPS next Q0.21 Inst Own73.10% Short Float6.32% Perf Quarter-28.54%
Sales3.77B P/S0.82 EPS this Y24.10% Inst Trans- Short Ratio4.60 Perf Half Y-
Book/sh20.56 P/B1.37 EPS next Y49.68% ROA- Target Price40.67 Perf Year-
Cash/sh0.21 P/C132.47 EPS next 5Y17.65% ROE- 52W Range27.02 - 50.00 Perf YTD-33.05%
Dividend- P/FCF- EPS past 5Y- ROI6.90% 52W High-43.76% Beta-
Dividend %- Quick Ratio0.90 Sales past 5Y- Gross Margin- 52W Low4.05% ATR1.38
Employees5000 Current Ratio1.90 Sales Q/Q-1.50% Oper. Margin- RSI (14)29.89 Volatility8.46% 4.14%
OptionableYes Debt/Eq0.02 EPS Q/Q77.40% Profit Margin- Rel Volume1.05 Prev Close28.69
ShortableYes LT Debt/Eq0.02 EarningsMay 15 BMO Payout- Avg Volume1.35M Price28.12
Recom1.80 SMA20-10.18% SMA50-13.54% SMA200-17.54% Volume1,415,984 Change-1.99%
Apr-04-19Initiated Credit Suisse Neutral $35
Feb-28-19Initiated Raymond James Outperform $45
May-15-19 05:36PM  Covetrus, Inc. (CVET) Q1 2019 Earnings Call Transcript Motley Fool
07:17AM  Covetrus: 1Q Earnings Snapshot Associated Press
07:00AM  Covetrus Announces Financial Results for First Quarter of 2019 GlobeNewswire
May-10-19 09:27AM  Are Investors Undervaluing Covetrus, Inc. (NASDAQ:CVET) By 37%? Simply Wall St. -5.09%
May-09-19 07:07AM  New England Venture Capital Association names 2019 NEVY Awards winners American City Business Journals
May-08-19 12:16PM  Software Stock Earnings Due on May 9: ACIW, SYMC, CISN, CVET Zacks -5.10%
May-07-19 04:59PM  Covetrus Reschedules First Quarter 2019 Earnings Release and Conference Call to May 15 and Files Historical Pro Forma 2018 Financial Information GlobeNewswire
May-06-19 09:00AM  Covetrus Announces New Partnership with Mars Petcare for GREENIES Products Business Wire
Apr-24-19 10:00AM  Covetrus Announces First Quarter 2019 Earnings Release Date and Conference Call Information GlobeNewswire
Mar-26-19 09:00AM  Covetrus Announces Appointment of Matthew Leonard as Executive Vice President, President North America and Global Supply Chain Officer Business Wire
Covetrus, Inc. operates as an animal-health technology and services company. It operates through two segments, Supply Chain, and Technology and Value-Added Services. The company sells and distributes pharmaceuticals, nutrition products, consumable products, diagnostic tests, small and large equipment, laboratory and surgical products, and others. It also provides technology solutions and services, including data-driven applications, client communications tools, and related services, as well as computer hardware for animal health customers; and software support, data driven application, training and education, client communication, and value-added services. In addition, the company supports, develops, and offers veterinary practices with a range of veterinary software systems, such as AVImark, eVetPractice, ImproMed, ImproMed Equine, Robovet, RxWorks, and VisionVPM, as well as solutions that integrate with its software platforms comprising client communication services that include Vetstreet and Rapport, reminders, data backup services, hardware sales and support, and credit card processing. Further, it provides technology-enabled services, which comprises its prescription management platform to enhance medical compliance through proactive prescription management. The company serves animal health practices and clinics in the companion animal and equine markets in North America, Europe, and Australasia. Covetrus, Inc. is headquartered in Portland, Maine.